Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates

F1000Research
Martin L AshdownBrendon J Coventry

Abstract

Complete response (CR) rates reported for cytotoxic chemotherapy for late-stage cancer patients are generally low, with few exceptions, regardless of the solid cancer type or drug regimen. We investigated CR rates reported in the literature for clinical trials using chemotherapy alone, across a wide range of tumour types and chemotherapeutic regimens, to determine an overall CR rate for late-stage cancers. A total of 141 reports were located using the PubMed database. A meta-analysis was performed of reported CR from 68 chemotherapy trials (total 2732 patients) using standard agents across late-stage solid cancers-a binomial model with random effects was adopted. Mean CR rates were compared for different cancer types, and for chemotherapeutic agents with different mechanisms of action, using a logistic regression. Our results showed that the CR rates for chemotherapy treatment of late-stage cancer were generally low at 7.4%, regardless of the cancer type or drug regimen used. We found no evidence that CR rates differed between different chemotherapy drug types, but amongst different cancer types small CR differences were evident, although none exceeded a mean CR rate of 11%. This remarkable concordance of CR rates regardless of...Continue Reading

References

Jan 1, 1994·Scientific American·T Beardsley
May 29, 1997·The New England Journal of Medicine·J C Bailar, H L Gornik
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Apr 28, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D KaufmanW Stadler
Jan 6, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V HeinemannU Fink
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M. TrudeauB. Leyland-Jones
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M BaekelandtG B Kristensen
Aug 4, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V GebbiaS Palmeri
Jun 18, 2002·Journal of Korean Medical Science·Eun Kyung ChoTae Hoon Lee
Oct 16, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S E SouleL H Einhorn
Nov 28, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T W KimJ S Lee
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diane C BodurkaDavid M Gershenson
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kurt A JaeckleUNKNOWN North American Brain Tumor Consortium
Jul 11, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G AravantinosM A Dimopoulos
Jul 11, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R D PettyUNKNOWN Aberdeen Pancreatic Cancer Focus Group
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paula M FracassoJames S Hoffman
May 14, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Edith A PerezRandolph S Marks
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezShaker R Dakhil

❮ Previous
Next ❯

Citations

Nov 16, 2017·International Journal of Molecular Sciences·Carmen W H ChanMary M Y Waye
Aug 12, 2018·Scientific Reports·Mohsen DorrakiDerek Abbott
Feb 9, 2017·Frontiers in Pharmacology·Loh Teng-Hern TanBey-Hing Goh
Jun 26, 2020·International Journal of Molecular Sciences·Omid KooshkakiBehzad Baradaran
Dec 19, 2020·BMJ Supportive & Palliative Care·Rafael CaparicaMilena Mak
Jul 1, 2020·Cancer Metastasis Reviews·Yang PengYutaka Kondo

❮ Previous
Next ❯

Software Mentioned

R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Treatment Options in Oncology
Mamta Bagia, Anna K Nowak
Informatics for Health & Social Care
Fadi M Alkhateeb, William R Doucette
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
L M StrawnJ M Cherrington
© 2021 Meta ULC. All rights reserved